Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zai Lab (ZLAB) Capital Expenditures (2018 - 2025)

Historic Capital Expenditures for Zai Lab (ZLAB) over the last 8 years, with Q3 2025 value amounting to $3.0 million.

  • Zai Lab's Capital Expenditures rose 12391.95% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.0 million, marking a year-over-year increase of 20570.3%. This contributed to the annual value of $5.7 million for FY2024, which is 2156.13% down from last year.
  • As of Q3 2025, Zai Lab's Capital Expenditures stood at $3.0 million, which was up 12391.95% from $2.9 million recorded in Q2 2025.
  • Zai Lab's Capital Expenditures' 5-year high stood at $9.7 million during Q1 2022, with a 5-year trough of $222000.0 in Q4 2023.
  • For the 5-year period, Zai Lab's Capital Expenditures averaged around $3.3 million, with its median value being $2.9 million (2025).
  • Per our database at Business Quant, Zai Lab's Capital Expenditures skyrocketed by 142461.54% in 2021 and then tumbled by 9496.94% in 2023.
  • Quarter analysis of 5 years shows Zai Lab's Capital Expenditures stood at $6.4 million in 2021, then crashed by 30.81% to $4.4 million in 2022, then tumbled by 94.97% to $222000.0 in 2023, then soared by 1071.17% to $2.6 million in 2024, then increased by 15.58% to $3.0 million in 2025.
  • Its Capital Expenditures stands at $3.0 million for Q3 2025, versus $2.9 million for Q2 2025 and $1.5 million for Q1 2025.